Calidi Biotherapeutics (CLDI) Prepaid Assets (2021 - 2025)

Calidi Biotherapeutics has reported Prepaid Assets for 5 years, with the latest figure at $234000.0 in Q4 2025.

• For the quarter ending Q4 2025, Prepaid Assets fell 18.75% year-over-year to $234000.0; the trailing twelve-month figure through Dec 2025 stood at $234000.0 (down 18.75% YoY), and the FY2025 full-year result was $234000.0, down 18.75% from the prior year.
• Prepaid Assets for Q4 2025 stood at $234000.0, down from $653000.0 in the prior quarter.
• The five-year high for Prepaid Assets was $2.4 million in Q4 2023, with the low at $124741.0 in Q2 2023.
• Average Prepaid Assets over 5 years is $587163.2, with a median of $420908.0 recorded in 2021.
• Peak annual rise in Prepaid Assets reached 532.51% in 2024, while the deepest fall reached 87.77% in 2024.
• Tracing CLDI's Prepaid Assets over 5 years: stood at $420908.0 in 2021, then dropped by 1.64% to $414000.0 in 2022, then surged by 468.6% to $2.4 million in 2023, then tumbled by 87.77% to $288000.0 in 2024, then decreased by 18.75% to $234000.0 in 2025.
• The last three Prepaid Assets figures came in at $234000.0 (Q4 2025), $653000.0 (Q3 2025), and $214000.0 (Q2 2025), per Business Quant data.

Peer Comparison